Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 1|pp. 857–871
Treatment patterns and survival analysis in patients with unresectable stage III EGFR-mutated non-small cell lung cancer
Back to articleFigure 5(5 of 6)
100%
Figure 5
Figure 5.Locoregional-free survival between TKI alone and TKI+chemotherapy groups. (A) The unmatched cohort. (B) The propensity score matching cohort.